PRKRA: Difference between revisions
Jump to navigation
Jump to search
m Robot: Automated text replacement (-{{reflist}} +{{reflist|2}}, -<references /> +{{reflist|2}}, -{{WikiDoc Cardiology Network Infobox}} +) |
m →top: bold |
||
Line 1: | Line 1: | ||
< | {{Infobox_gene}} | ||
{{ | '''Protein kinase, interferon-inducible double stranded RNA dependent activator''', also known as '''interferon-inducible double stranded RNA-dependent protein kinase activator A''' or '''<u>P</u>rotein <u>ACT</u>ivator of the interferon-induced protein kinase''' ('''PACT''') is a [[protein]] that in humans is encoded by the ''PRKRA'' [[gene]].<ref name="entrez">{{cite web | title = Entrez Gene: PRKRA protein kinase, interferon-inducible double stranded RNA dependent activator| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=8575| accessdate = }}</ref><ref name="pmid9687506"/><ref name="pmid10336432">{{cite journal | vauthors = Ito T, Yang M, May WS | title = RAX, a cellular activator for double-stranded RNA-dependent protein kinase during stress signaling | journal = J. Biol. Chem. | volume = 274 | issue = 22 | pages = 15427–32 |date=May 1999 | pmid = 10336432 | doi = 10.1074/jbc.274.22.15427| url = | issn = }}</ref> PACT heterodimerizes with and activates [[protein kinase R]].<ref name="pmid9687506">{{cite journal | vauthors = Patel RC, Sen GC | title = PACT, a protein activator of the interferon-induced protein kinase, PKR | journal = EMBO J. | volume = 17 | issue = 15 | pages = 4379–90 |date=August 1998 | pmid = 9687506 | pmc = 1170771 | doi = 10.1093/emboj/17.15.4379 | url = | issn = }}</ref><ref name="pmid11985496">{{cite journal | vauthors = Huang X, Hutchins B, Patel RC | title = The C-terminal, third conserved motif of the protein activator PACT plays an essential role in the activation of double-stranded-RNA-dependent protein kinase (PKR) | journal = Biochem. J. | volume = 366 | issue = Pt 1 | pages = 175–86 |date=August 2002 | pmid = 11985496 | pmc = 1222748 | doi = 10.1042/BJ20020204 | url = | issn = }}</ref> | ||
| | PRKRA mutations have been linked to a rare form of dystonia parkinsonism.<ref name="pmid18243799">{{cite journal | vauthors = Camargos S, Scholz S, Simón-Sánchez J, Paisán-Ruiz C, Lewis P, Hernandez D, Ding J, Gibbs JR, Cookson MR, Bras J, Guerreiro R, Oliveira CR, Lees A, Hardy J, Cardoso F, Singleton AB | title = DYT16, a novel young-onset dystonia-parkinsonism disorder: identification of a segregating mutation in the stress-response protein PRKRA | journal = Lancet Neurology | volume = 7 | issue = 3 | pages = 207–215 |date=March 2008 | pmid = 18243799 | doi = 10.1016/S1474-4422(08)70022-X | url = | issn = }}</ref> | ||
| | |||
| | |||
| | |||
| | |||
}} | |||
==References== | |||
{{reflist}} | |||
}} | |||
==Further reading== | ==Further reading== | ||
{{refbegin | 2}} | {{refbegin | 2}} | ||
{{PBB_Further_reading | {{PBB_Further_reading | ||
| citations = | | citations = | ||
*{{cite journal | | *{{cite journal | vauthors=Maruyama K, Sugano S |title=Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides. |journal=Gene |volume=138 |issue= 1–2 |pages= 171–4 |year= 1994 |pmid= 8125298 |doi=10.1016/0378-1119(94)90802-8 }} | ||
*{{cite journal | *{{cite journal |vauthors=Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, etal |title=Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library |journal=Gene |volume=200 |issue= 1–2 |pages= 149–56 |year= 1997 |pmid= 9373149 |doi=10.1016/S0378-1119(97)00411-3 }} | ||
*{{cite journal | *{{cite journal |vauthors=Peters GA, Hartmann R, Qin J, etal |title=Modular structure of PACT: distinct domains for binding and activating PKR |journal=Mol Cell Biol |volume=21 |issue= 6 |pages= 1908–20 |year= 2001 |pmid= 11238927 |doi=10.1128/MCB.21.6.1908-1920.2001 |pmc=86773}} | ||
*{{cite journal | *{{cite journal |vauthors=Wiemann S, Weil B, Wellenreuther R, etal |title=Toward a catalog of human genes and proteins: sequencing and analysis of 500 novel complete protein coding human cDNAs |journal=Genome Res. |volume=11 |issue= 3 |pages= 422–35 |year= 2001 |pmid= 11230166 |doi= 10.1101/gr.GR1547R | pmc=311072 }} | ||
*{{cite journal | *{{cite journal |vauthors=Simpson JC, Wellenreuther R, Poustka A, etal |title=Systematic subcellular localization of novel proteins identified by large-scale cDNA sequencing |journal=EMBO Rep. |volume=1 |issue= 3 |pages= 287–92 |year= 2001 |pmid= 11256614 |doi= 10.1093/embo-reports/kvd058 | pmc=1083732 }} | ||
*{{cite journal | | *{{cite journal | vauthors=Horng T, Barton GM, Medzhitov R |title=TIRAP: an adapter molecule in the Toll signaling pathway |journal=Nat. Immunol. |volume=2 |issue= 9 |pages= 835–41 |year= 2001 |pmid= 11526399 |doi= 10.1038/ni0901-835 }} | ||
*{{cite journal | | *{{cite journal | vauthors=Huang X, Hutchins B, Patel RC |title=The C-terminal, third conserved motif of the protein activator PACT plays an essential role in the activation of double-stranded-RNA-dependent protein kinase (PKR) |journal=Biochem. J. |volume=366 |issue= Pt 1 |pages= 175–86 |year= 2002 |pmid= 11985496 |doi= 10.1042/BJ20020204 | pmc=1222748 }} | ||
*{{cite journal | | *{{cite journal | vauthors=Peters GA, Khoo D, Mohr I, Sen GC |title=Inhibition of PACT-mediated activation of PKR by the herpes simplex virus type 1 Us11 protein |journal=J. Virol. |volume=76 |issue= 21 |pages= 11054–64 |year= 2002 |pmid= 12368348 |doi=10.1128/JVI.76.21.11054-11064.2002 | pmc=136652 }} | ||
*{{cite journal | *{{cite journal |vauthors=Strausberg RL, Feingold EA, Grouse LH, etal |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899–903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899 | pmc=139241 }} | ||
*{{cite journal | | *{{cite journal | vauthors=Yang M, Ito T, May WS |title=A novel role for RAX, the cellular activator of PKR, in synergistically stimulating SV40 large T antigen-dependent gene expression |journal=J. Biol. Chem. |volume=278 |issue= 40 |pages= 38325–32 |year= 2003 |pmid= 12874289 |doi= 10.1074/jbc.M303420200 }} | ||
*{{cite journal | *{{cite journal |vauthors=Ota T, Suzuki Y, Nishikawa T, etal |title=Complete sequencing and characterization of 21,243 full-length human cDNAs |journal=Nat. Genet. |volume=36 |issue= 1 |pages= 40–5 |year= 2004 |pmid= 14702039 |doi= 10.1038/ng1285 }} | ||
*{{cite journal | | *{{cite journal | vauthors=Bennett RL, Blalock WL, May WS |title=Serine 18 phosphorylation of RAX, the PKR activator, is required for PKR activation and consequent translation inhibition |journal=J. Biol. Chem. |volume=279 |issue= 41 |pages= 42687–93 |year= 2004 |pmid= 15299031 |doi= 10.1074/jbc.M403321200 }} | ||
*{{cite journal | *{{cite journal |vauthors=Gerhard DS, Wagner L, Feingold EA, etal |title=The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC) |journal=Genome Res. |volume=14 |issue= 10B |pages= 2121–7 |year= 2004 |pmid= 15489334 |doi= 10.1101/gr.2596504 | pmc=528928 }} | ||
*{{cite journal | *{{cite journal |vauthors=Hillier LW, Graves TA, Fulton RS, etal |title=Generation and annotation of the DNA sequences of human chromosomes 2 and 4 |journal=Nature |volume=434 |issue= 7034 |pages= 724–31 |year= 2005 |pmid= 15815621 |doi= 10.1038/nature03466 }} | ||
*{{cite journal | *{{cite journal |vauthors=Stelzl U, Worm U, Lalowski M, etal |title=A human protein-protein interaction network: a resource for annotating the proteome |journal=Cell |volume=122 |issue= 6 |pages= 957–68 |year= 2005 |pmid= 16169070 |doi= 10.1016/j.cell.2005.08.029 }} | ||
*{{cite journal | *{{cite journal |vauthors=Rual JF, Venkatesan K, Hao T, etal |title=Towards a proteome-scale map of the human protein-protein interaction network |journal=Nature |volume=437 |issue= 7062 |pages= 1173–8 |year= 2005 |pmid= 16189514 |doi= 10.1038/nature04209 }} | ||
*{{cite journal | | *{{cite journal | vauthors=Peters GA, Li S, Sen GC |title=Phosphorylation of specific serine residues in the PKR-activation domain of PACT is essential for its ability to mediate apoptosis |journal=J Biol Chem |volume=281 |issue= 46 |pages= 35129–36 |year= 2006 |pmid= 16982605 |doi=10.1074/jbc.M607714200}} | ||
*{{cite journal | *{{cite journal |vauthors=Rowe TM, Rizzi M, Hirose K, Peters GA, etal |title=A role of the double-stranded RNA-binding protein PACT in mouse ear development and hearing|journal=Proc Natl Acad Sci USA |volume=103 |issue= 15 |pages= 5823–8 |year= 2006 |pmid= 16571658 |doi=10.1073/pnas.0601287103 |pmc=1458657}} | ||
*{{cite journal | *{{cite journal |vauthors=Li S, Peters GA, Ding K, etal |title=Molecular basis for PKR activation by PACT or dsRNA|journal=Proc Natl Acad Sci USA |volume=103 |issue= 26 |pages= 10005–10 |year= 2006 |pmid= 16785445 |doi=10.1073/pnas.0602317103 |pmc=1502496}} | ||
*{{cite journal | *{{cite journal |vauthors=Lee Y, Hur I, Park SY, etal |title=The role of PACT in the RNA silencing pathway |journal=EMBO J. |volume=25 |issue= 3 |pages= 522–32 |year= 2006 |pmid= 16424907 |doi= 10.1038/sj.emboj.7600942 | pmc=1383527 }} | ||
*{{cite journal |vauthors=Bennett RL, Blalock WL, Abtahi DM, etal |title=RAX, the PKR activator, sensitizes cells to inflammatory cytokines, serum withdrawal, chemotherapy, and viral infection |journal=Blood |volume=108 |issue= 3 |pages= 821–9 |year= 2006 |pmid= 16861340 |doi= 10.1182/blood-2005-11-006817 | pmc=1617065 }} | |||
*{{cite journal |vauthors=Peters GA, Seachrist DD, Keri RA, etal |title=The double-stranded RNA-binding protein, PACT, is required for postnatal anterior pituitary proliferation |journal=Proc Natl Acad Sci USA |volume=106 |issue= 26 |pages= 10696–701 |year= 2009 |pmid= 19541653 |doi=10.1073/pnas.0900735106 |pmc=2705576}} | |||
}} | }} | ||
{{refend}} | {{refend}} | ||
{{PDB Gallery|geneid=8575}} | |||
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. --> | |||
{{PBB_Controls | |||
| update_page = yes | |||
| require_manual_inspection = no | |||
| update_protein_box = yes | |||
| update_summary = no | |||
| update_citations = no | |||
}} | |||
{{ | {{gene-2-stub}} | ||
Latest revision as of 20:48, 9 September 2017
VALUE_ERROR (nil) | |||||||
---|---|---|---|---|---|---|---|
Identifiers | |||||||
Aliases | |||||||
External IDs | GeneCards: [1] | ||||||
Orthologs | |||||||
Species | Human | Mouse | |||||
Entrez |
|
| |||||
Ensembl |
|
| |||||
UniProt |
|
| |||||
RefSeq (mRNA) |
|
| |||||
RefSeq (protein) |
|
| |||||
Location (UCSC) | n/a | n/a | |||||
PubMed search | n/a | n/a | |||||
Wikidata | |||||||
|
Protein kinase, interferon-inducible double stranded RNA dependent activator, also known as interferon-inducible double stranded RNA-dependent protein kinase activator A or Protein ACTivator of the interferon-induced protein kinase (PACT) is a protein that in humans is encoded by the PRKRA gene.[1][2][3] PACT heterodimerizes with and activates protein kinase R.[2][4] PRKRA mutations have been linked to a rare form of dystonia parkinsonism.[5]
References
- ↑ "Entrez Gene: PRKRA protein kinase, interferon-inducible double stranded RNA dependent activator".
- ↑ 2.0 2.1 Patel RC, Sen GC (August 1998). "PACT, a protein activator of the interferon-induced protein kinase, PKR". EMBO J. 17 (15): 4379–90. doi:10.1093/emboj/17.15.4379. PMC 1170771. PMID 9687506.
- ↑ Ito T, Yang M, May WS (May 1999). "RAX, a cellular activator for double-stranded RNA-dependent protein kinase during stress signaling". J. Biol. Chem. 274 (22): 15427–32. doi:10.1074/jbc.274.22.15427. PMID 10336432.
- ↑ Huang X, Hutchins B, Patel RC (August 2002). "The C-terminal, third conserved motif of the protein activator PACT plays an essential role in the activation of double-stranded-RNA-dependent protein kinase (PKR)". Biochem. J. 366 (Pt 1): 175–86. doi:10.1042/BJ20020204. PMC 1222748. PMID 11985496.
- ↑ Camargos S, Scholz S, Simón-Sánchez J, Paisán-Ruiz C, Lewis P, Hernandez D, Ding J, Gibbs JR, Cookson MR, Bras J, Guerreiro R, Oliveira CR, Lees A, Hardy J, Cardoso F, Singleton AB (March 2008). "DYT16, a novel young-onset dystonia-parkinsonism disorder: identification of a segregating mutation in the stress-response protein PRKRA". Lancet Neurology. 7 (3): 207–215. doi:10.1016/S1474-4422(08)70022-X. PMID 18243799.
Further reading
- Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID 8125298.
- Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene. 200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID 9373149.
- Peters GA, Hartmann R, Qin J, et al. (2001). "Modular structure of PACT: distinct domains for binding and activating PKR". Mol Cell Biol. 21 (6): 1908–20. doi:10.1128/MCB.21.6.1908-1920.2001. PMC 86773. PMID 11238927.
- Wiemann S, Weil B, Wellenreuther R, et al. (2001). "Toward a catalog of human genes and proteins: sequencing and analysis of 500 novel complete protein coding human cDNAs". Genome Res. 11 (3): 422–35. doi:10.1101/gr.GR1547R. PMC 311072. PMID 11230166.
- Simpson JC, Wellenreuther R, Poustka A, et al. (2001). "Systematic subcellular localization of novel proteins identified by large-scale cDNA sequencing". EMBO Rep. 1 (3): 287–92. doi:10.1093/embo-reports/kvd058. PMC 1083732. PMID 11256614.
- Horng T, Barton GM, Medzhitov R (2001). "TIRAP: an adapter molecule in the Toll signaling pathway". Nat. Immunol. 2 (9): 835–41. doi:10.1038/ni0901-835. PMID 11526399.
- Huang X, Hutchins B, Patel RC (2002). "The C-terminal, third conserved motif of the protein activator PACT plays an essential role in the activation of double-stranded-RNA-dependent protein kinase (PKR)". Biochem. J. 366 (Pt 1): 175–86. doi:10.1042/BJ20020204. PMC 1222748. PMID 11985496.
- Peters GA, Khoo D, Mohr I, Sen GC (2002). "Inhibition of PACT-mediated activation of PKR by the herpes simplex virus type 1 Us11 protein". J. Virol. 76 (21): 11054–64. doi:10.1128/JVI.76.21.11054-11064.2002. PMC 136652. PMID 12368348.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Yang M, Ito T, May WS (2003). "A novel role for RAX, the cellular activator of PKR, in synergistically stimulating SV40 large T antigen-dependent gene expression". J. Biol. Chem. 278 (40): 38325–32. doi:10.1074/jbc.M303420200. PMID 12874289.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.
- Bennett RL, Blalock WL, May WS (2004). "Serine 18 phosphorylation of RAX, the PKR activator, is required for PKR activation and consequent translation inhibition". J. Biol. Chem. 279 (41): 42687–93. doi:10.1074/jbc.M403321200. PMID 15299031.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Hillier LW, Graves TA, Fulton RS, et al. (2005). "Generation and annotation of the DNA sequences of human chromosomes 2 and 4". Nature. 434 (7034): 724–31. doi:10.1038/nature03466. PMID 15815621.
- Stelzl U, Worm U, Lalowski M, et al. (2005). "A human protein-protein interaction network: a resource for annotating the proteome". Cell. 122 (6): 957–68. doi:10.1016/j.cell.2005.08.029. PMID 16169070.
- Rual JF, Venkatesan K, Hao T, et al. (2005). "Towards a proteome-scale map of the human protein-protein interaction network". Nature. 437 (7062): 1173–8. doi:10.1038/nature04209. PMID 16189514.
- Peters GA, Li S, Sen GC (2006). "Phosphorylation of specific serine residues in the PKR-activation domain of PACT is essential for its ability to mediate apoptosis". J Biol Chem. 281 (46): 35129–36. doi:10.1074/jbc.M607714200. PMID 16982605.
- Rowe TM, Rizzi M, Hirose K, Peters GA, et al. (2006). "A role of the double-stranded RNA-binding protein PACT in mouse ear development and hearing". Proc Natl Acad Sci USA. 103 (15): 5823–8. doi:10.1073/pnas.0601287103. PMC 1458657. PMID 16571658.
- Li S, Peters GA, Ding K, et al. (2006). "Molecular basis for PKR activation by PACT or dsRNA". Proc Natl Acad Sci USA. 103 (26): 10005–10. doi:10.1073/pnas.0602317103. PMC 1502496. PMID 16785445.
- Lee Y, Hur I, Park SY, et al. (2006). "The role of PACT in the RNA silencing pathway". EMBO J. 25 (3): 522–32. doi:10.1038/sj.emboj.7600942. PMC 1383527. PMID 16424907.
- Bennett RL, Blalock WL, Abtahi DM, et al. (2006). "RAX, the PKR activator, sensitizes cells to inflammatory cytokines, serum withdrawal, chemotherapy, and viral infection". Blood. 108 (3): 821–9. doi:10.1182/blood-2005-11-006817. PMC 1617065. PMID 16861340.
- Peters GA, Seachrist DD, Keri RA, et al. (2009). "The double-stranded RNA-binding protein, PACT, is required for postnatal anterior pituitary proliferation". Proc Natl Acad Sci USA. 106 (26): 10696–701. doi:10.1073/pnas.0900735106. PMC 2705576. PMID 19541653.
This article on a gene on human chromosome 2 is a stub. You can help Wikipedia by expanding it. |